Retrospective Study of Risk Factors Associated With Hepatic Dysfunction Induced by Daclatasvir/Asunaprevir

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
doi 10.5649/jjphcs.44.29
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Pharmaceutical Health Care and Sciences

Related search

Risk Factors for Hepatic Veno-Occlusive Disease Caused by Gynura Segetum: A Retrospective Study

BMC Gastroenterology
MedicineGastroenterology
2018English

Hepatic Impairment Induced by Scrub Typhus Is Associated With New Onset of Renal Dysfunction

Clinical Laboratory
BiochemistryGeneticsMolecular Biology
2014English

Hemoglobin Decrease With Iron Deficiency Induced by Daclatasvir Plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b

PLoS ONE
Multidisciplinary
2016English

A Study on Hepatic Dysfunction Associated With Rubella Infection

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
Medicine
1991English

Raltegravir Pharmacokinetics in Patients on Asunaprevir-Daclatasvir: TABLE 1

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2015English

Correlation Between Efficacy of Daclatasvir/Asunaprevir Combination Therapy and HCV NS3/NS5A Resistance-Associated Variants Detected by the PCR-Invader Assay

Acta Hepatologica Japonica
Hepatology
2015English

Potential Risk Factors for Nivolumab-Induced Thyroid Dysfunction

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2017English

Changes in Serum LDL, PCSK9 and microRNA‑122 in Patients With Chronic HCV Infection Receiving Daclatasvir/Asunaprevir

Biomedical Reports
GeneticsPharmacologyMolecular BiologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2019English

Risk Factors and Mediators of the Vascular Dysfunction Associated With Hypertension in Pregnancy

Cardiovascular and Hematological Disorders - Drug Targets
Molecular MedicinePharmacologyCardiologyHematologyCardiovascular MedicineMedicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy